Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.

Metric
Company Name	Alfresa Holdings Corporation
Symbol	2.78K
MSH ID	COM:ALFRESA
Market	STOCKS
Sector	Healthcare
Industry	Medical - Distribution
Country	JP
Stage
Employee Count	12.52K
Website	alfresa.com
LinkedIn
Founders

Metric
Market Cap	2.83B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	19.06B
Revenue (LTM)
Revenue (NTM)
Gross Profit	1.31B
EBITDA	346.65M
Operating Income	256.52M
Net Income	197.13M
EPS	1.03
Diluted EPS	1.03
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.07
Operating Profit Margin	0.01
EBITDA Margin	0.02
Net Profit Margin	0.01
Return on Equity	0.07
Return on Assets	0.02
Return on Capital Employed	0.08

2784

COM:ALFRESA

Alfresa Group

Last Close

2,274.50

25/11 06:45

Market Cap

423.82B

Beta: -

Volume Today

823.70K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	14.93
P/B Ratio	0.98
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.16
EV Multiple	14.65

Metric
Days Sales Outstanding	87.42
Days Payables Outstanding	122.87
Days Inventory Outstanding	24.42
Operating Cycle	115.11
Cash Conversion Cycle	-2.60
Asset Turnover	1.97

Metric
Operating Cash Flow	576.09M
Free Cash Flow	471.26M
Cash Flow to Debt	0.90
Operating Cash Flow/Sales	0.01
Free Cash Flow Yield

Metric
Cash & Equivalents	1.43B
Accounts Receivable	-168.02M
Inventory	1.04B
Goodwill	13.77M
Debt to Capitalization	0.06
Debt to Assets	0.01
Current Ratio	1.19
Quick Ratio	1.06

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue